Each tablet contains BisoprololFumarate USP 2.5mg & Amlodipine USP 5mg Tablet
Bisoprolol Plus Amlodipine is indicated for the treatment of hypertension and angina. It is also indicated for the treatment of hypertension and substitution therapy in patient adequately controlled or not controlled with the individual product given concurrently at the same dosage level as in the combination, but as separate tablet. It is also indicated for those patient with angina pectoris and hypertension as co-existing disease.
Each tablet contains BisoprololFumarate USP 2.5mg & Amlodipine USP 5mg Tablet
Bisoprolol Plus Amlodipine is indicated for the treatment of hypertension and angina. It is also indicated for the treatment of hypertension and substitution therapy in patient adequately controlled or not controlled with the individual product given concurrently at the same dosage level as in the combination, but as separate tablet. It is also indicated for those patient with angina pectoris and hypertension as co-existing disease.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.